BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30358629)

  • 1. In Vitro Analysis of the Degradation of Calcium Hydroxylapatite Dermal Filler: A Proof-of-Concept Study.
    Robinson DM
    Dermatol Surg; 2018 Nov; 44 Suppl 1():S5-S9. PubMed ID: 30358629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarterial Degradation of Calcium Hydroxylapatite Using Sodium Thiosulfate - An In Vitro and Cadaveric Study.
    Yankova M; Pavicic T; Frank K; Schenck TL; Beleznay K; Gavril DL; Green JB; Voropai D; Robinson DM; Cotofana S
    Aesthet Surg J; 2021 Apr; 41(5):NP226-NP236. PubMed ID: 33544840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-Label, Post-Marketing Study to Evaluate the Performance and Safety of Calcium Hydroxylapatite With Integral Lidocaine to Correct Facial Volume Loss.
    Muti GF
    J Drugs Dermatol; 2019 Jan; 18(1):86-91. PubMed ID: 30681803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study.
    Danysz W; Nowag B; Hengl T; Kreymerman P; Furne C; Madeuf E; Höennscheidt C; Mraz Robinson D
    Clin Cosmet Investig Dermatol; 2020; 13():1059-1073. PubMed ID: 33408497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium hydroxylapatite: A review on safety and complications.
    Kadouch JA
    J Cosmet Dermatol; 2017 Jun; 16(2):152-161. PubMed ID: 28247924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining topical dermal infused exosomes with injected calcium hydroxylapatite for enhanced tissue biostimulation.
    Chernoff G
    J Cosmet Dermatol; 2023 Mar; 22 Suppl 1():15-27. PubMed ID: 36988469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.
    van Loghem J; Funt D; Pavicic T; Goldie K; Yutskovskaya Y; Fabi S; Siebenga P; Thuis J; Hkeik J; Kadouch J; Prager W; Azib N; Casabona G; Dayan S; Bay Aguilera S; Snozzi P; Saeed P
    J Cosmet Dermatol; 2020 Nov; 19(11):2845-2858. PubMed ID: 32185876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of calcium hydroxylapatite in the upper third of the face: Retrospective analysis of techniques, dilutions and adverse events.
    Van Loghem JAJ
    J Cosmet Dermatol; 2018 Dec; 17(6):1025-1030. PubMed ID: 30362225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
    Emer J; Sundaram H
    J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler.
    Yutskovskaya Y; Kogan E; Leshunov E
    J Drugs Dermatol; 2014 Sep; 13(9):1047-52. PubMed ID: 25226004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of polycaprolactone and calcium hydroxylapatite dermal fillers in a rat model.
    Yanatma I; Sarac G; Gul M; Gul S; Kapicioglu Y
    Dermatol Ther; 2021 Jan; 34(1):e14716. PubMed ID: 33368862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium Hydroxylapatite Dermal Filler for Treatment of Dorsal Hand Volume Loss: Results From a 12-Month, Multicenter, Randomized, Blinded Trial.
    Goldman MP; Moradi A; Gold MH; Friedmann DP; Alizadeh K; Adelglass JM; Katz BE
    Dermatol Surg; 2018 Jan; 44(1):75-83. PubMed ID: 28562435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium hydroxylapatite filler: an overview of safety and tolerability.
    Pavicic T
    J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective, Multicenter, Evaluator-Blinded, Randomized Study of Diluted Calcium Hydroxylapatite to Treat Decollete Wrinkles.
    Pavicic T; Kerscher M; Kuhne U; Heide I; Dersch H; Odena G; Graul V
    J Drugs Dermatol; 2024 Jul; 23(7):551-556. PubMed ID: 38954627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheological Properties of Calcium Hydroxylapatite With Integral Lidocaine.
    Meland M; Groppi C; Lorenc ZP
    J Drugs Dermatol; 2016 Sep; 15(9):1107-10. PubMed ID: 27602973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Intralesional Sodium Thiosulfate to Dissolve Facial Nodules From Calcium Hydroxylapatite.
    Rullan PP; Olson R; Lee KC
    Dermatol Surg; 2020 Oct; 46(10):1366-1368. PubMed ID: 31688231
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiesse Rescue: A Preliminary Study for a Simple and Effective Technique for the Removal of Calcium Hydroxyapatite-Based Fillers.
    Cohen SR; Patton S; Wesson J; Tiryaki KT; Mora A
    Aesthet Surg J; 2023 Feb; 43(3):365-369. PubMed ID: 36411258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiochemical Characteristics of Calcium Hydroxylapatite (CaHA).
    Lorenc ZP; Bass LM; Fitzgerald R; Goldberg DJ; Graivier MH
    Aesthet Surg J; 2018 Apr; 38(suppl_1):S8-S12. PubMed ID: 29897516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler.
    Marmur ES; Phelps R; Goldberg DJ
    J Cosmet Laser Ther; 2004 Dec; 6(4):223-6. PubMed ID: 16020207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilayered injection of calcium hydroxylapatite filler on ischial soft tissue to rejuvenate the previous phase of chronic sitting pressure sore.
    Kim J
    Clin Cosmet Investig Dermatol; 2019; 12():771-784. PubMed ID: 31686889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.